C
Christiana Franke
Researcher at Charité
Publications - 38
Citations - 1063
Christiana Franke is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 26 publications receiving 486 citations. Previous affiliations of Christiana Franke include Ludwig Maximilian University of Munich & German Center for Neurodegenerative Diseases.
Papers
More filters
Journal ArticleDOI
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
Jakob Kreye,S. Momsen Reincke,Hans Christian Kornau,Hans Christian Kornau,Elisa Sanchez-Sendin,Elisa Sanchez-Sendin,Elisa Sanchez-Sendin,Victor M. Corman,Hejun Liu,Meng Yuan,Nicholas C. Wu,Xueyong Zhu,Chang-Chun D Lee,Jakob Trimpert,Markus Höltje,Kristina Dietert,Laura Stöffler,Laura Stöffler,Niels von Wardenburg,Niels von Wardenburg,Scott van Hoof,Scott van Hoof,Scott van Hoof,Marie A Homeyer,Marie A Homeyer,Julius Hoffmann,Julius Hoffmann,Azza Abdelgawad,Achim D. Gruber,Luca D. Bertzbach,Daria Vladimirova,Lucie Y Li,Lucie Y Li,Paula Charlotte Barthel,Karl Skriner,Andreas C. Hocke,Stefan Hippenstiel,Martin Witzenrath,Norbert Suttorp,Florian Kurth,Florian Kurth,Christiana Franke,Matthias Endres,Dietmar Schmitz,Dietmar Schmitz,Lara Maria Jeworowski,Anja Richter,Marie Luisa Schmidt,Tatjana Schwarz,Marcel A. Müller,Christian Drosten,Daniel Wendisch,Leif E. Sander,Nikolaus Osterrieder,Nikolaus Osterrieder,Ian A. Wilson,Harald Prüss,Harald Prüss,Harald Prüss +58 more
TL;DR: Results show that non-self-reactive virus-neutralizing mAbs elicited during SARS-CoV-2 infection are a promising therapeutic strategy and should be guided by immunization strategies.
Journal ArticleDOI
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
Christiana Franke,Caroline Ferse,Jakob Kreye,S. Momsen Reincke,Elisa Sanchez-Sendin,Andrea Rocco,Mirja Steinbrenner,Stefan Angermair,Sascha Treskatsch,Daniel Zickler,Kai-Uwe Eckardt,Rick Dersch,Jonas A. Hosp,Heinrich J. Audebert,Matthias Endres,Christoph J. Ploner,Harald Prüß +16 more
TL;DR: In this paper, the authors analyzed blood and CSF samples from eleven critically ill COVID-19 patients presenting with unexplained neurological symptoms including myoclonus, oculomotor disturbance, delirium, dystonia and epileptic seizures, were analyzed for anti-neuronal and anti-glial autoantibodies.
Journal ArticleDOI
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Frank Jessen,Frank Jessen,Annika Spottke,Annika Spottke,Henning Boecker,Henning Boecker,Frederic Brosseron,Katharina Buerger,Katharina Buerger,Cihan Catak,Klaus Fliessbach,Klaus Fliessbach,Christiana Franke,Manuel Fuentes,Michael T. Heneka,Michael T. Heneka,Daniel Janowitz,Ingo Kilimann,Ingo Kilimann,Christoph Laske,Christoph Laske,Felix Menne,Peter J. Nestor,Oliver Peters,Josef Priller,Verena Pross,Alfredo Ramirez,Alfredo Ramirez,Anja Schneider,Anja Schneider,Oliver Speck,Eike Jakob Spruth,Stefan J. Teipel,Stefan J. Teipel,Ruth Vukovich,Christine Westerteicher,Christine Westerteicher,Jens Wiltfang,Jens Wiltfang,Jens Wiltfang,Steffen Wolfsgruber,Steffen Wolfsgruber,Michael Wagner,Michael Wagner,Emrah Düzel +44 more
TL;DR: The initial baseline data for DELCODE support the approach of using SCD in patients recruited through memory clinics as an enrichment strategy for late-stage preclinical AD.
Posted ContentDOI
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Christiana Franke,Caroline Ferse,Jakob Kreye,Momsen Reincke,Elisa Sanchez-Sendin,Andrea Rocco,Mirja Steinbrenner,Stefan Angermair,Sascha Treskatsch,Daniel Zickler,Kai-Uwe Eckardt,Rick Dersch,Jonas A. Hosp,Heinrich J. Audebert,Matthias Endres,Christoph J. Ploner,Harald Pruess +16 more
TL;DR: While several underlying autoantigens still await identification in future studies, presence of autoantibodies may explain some aspects of multi-organ disease in COVID-19 and can guide immunotherapy in selected cases.
Journal ArticleDOI
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
Nicolai Franzmeier,Emrah Düzel,Frank Jessen,Frank Jessen,Katharina Buerger,Katharina Buerger,Johannes Levin,Johannes Levin,Marco Duering,Martin Dichgans,Martin Dichgans,Christian Haass,Christian Haass,Marc Suárez-Calvet,Marc Suárez-Calvet,Anne M. Fagan,Katrina L. Paumier,Tammie L.S. Benzinger,Colin L. Masters,John C. Morris,Robert Perneczky,Daniel Janowitz,Cihan Catak,Steffen Wolfsgruber,Steffen Wolfsgruber,Michael Wagner,Michael Wagner,Stefan J. Teipel,Stefan J. Teipel,Ingo Kilimann,Ingo Kilimann,Alfredo Ramirez,Alfredo Ramirez,Martin N. Rossor,Mathias Jucker,Jasmeer P. Chhatwal,Annika Spottke,Annika Spottke,Henning Boecker,Henning Boecker,Frederic Brosseron,Frederic Brosseron,Peter Falkai,Peter Falkai,Klaus Fliessbach,Klaus Fliessbach,Michael T. Heneka,Michael T. Heneka,Christoph Laske,Christoph Laske,Peter J. Nestor,Peter J. Nestor,Oliver Peters,Oliver Peters,Manuel Fuentes,Felix Menne,Felix Menne,Josef Priller,Josef Priller,Eike Jakob Spruth,Eike Jakob Spruth,Christiana Franke,Christiana Franke,Anja Schneider,Anja Schneider,Barbara Kofler,Barbara Kofler,Christine Westerteicher,Christine Westerteicher,Oliver Speck,Jens Wiltfang,Jens Wiltfang,Jens Wiltfang,Claudia Bartels,Miguel Ángel Araque Caballero,Coraline D. Metzger,Daniel Bittner,Michael W. Weiner,Jae-Hong Lee,Stephen Salloway,Adrian Danek,Adrian Danek,Alison Goate,Peter R. Schofield,Peter R. Schofield,Randall J. Bateman,Michael Ewers +86 more
TL;DR: Franzmeier et al. show that greater left frontal hub connectivity within the fronto-parietal control network is associated with greater resilience of cognitive performance during the early stages of autosomal dominant and sporadic Alzheimer’s disease.